A CVC or central venous catheter, also popularly known as the central line, is defined as a tube that the doctors place in a large vein in the chest, neck, groin, or arm to provide blood, fluids, or medications or to perform the medical tests quickly. The Central Venous Catheter or CVC Market share was valued at USD 1.12 billion in 2020 & it’s predicted to reach around USD 1.93billion by 2030, with a 5.48% of growth rate.
Region-wise Prevailing Trends of The CVC Market
a.) THE NORTH AMERICAN TERRITORY
The overall growth rate for the CVC market in North America has shown a steady performance over the past few years. A steep surge in total number of cases of acute CVC is anticipated to apply upward pressure to the overall worth of the CVC market throughout the framed period. Further, the largest market segment of acute CVC represents the vast majority of the worldwide CVC market.
b.) LATIN AMERICA
Like the North American market, the CVC market in Latin America has been growing steadily and at a slightly higher CAGR value. The CVC market growth in Latin America is consistently hampered by the high risk & severity of infections that are associated with the usage of CVCs. Alternatives like PICCs have currently become more popular & hence have pushed the CVCs, especially the chronic CVCs, to the side. Over the past couple of years, the ASP of chronic CVCs in the Latin American region has been decreasing. Due to the risks that chronic CVCs cause to the patients, the costs for these devices are expected to plummet by 2026.
c.) THE EUROPEAN REGION
Overall, the CVC market in Europe is growing at a much lower rate. The acute CVC market is expected to foster slightly above the expected limit over the prevised period. Growth within the acute CVC segment is augmented by the increasing usage of the antimicrobial CVCs in case of the high-risk patients. All of these devices sell at a slight premium over that of the conventional devices, & the conversion to the antimicrobial CVCs will eventually lead to massive growth in the worldwide market value.
d.) THE MIDDLE-EAST REGION
By 2026, the CVC market in the Middle East is expected to foster at a seemingly stable rate. This shift towards acute CVCs is driven by the increasing physician desire for the minimization of complications that are associated with chronic CVCs, which is one of the major trends in the Middle East. Because of this market shift towards the acute CVCs, the overall sales unit are expected to increase with some of the most modest declines in the overall sales rate of the chronic CVCs.
e.) THE REGION OF ASIA-PACIFIC
CVCs within the Asia-Pacific region are showing some of the most indicative signs of growth by 2026. As usual, the acute CVCs were the largest segment & are expected to carry out their dominance for a longer period of time. Within the Asia-Pacific region, the global market value of the acute CVC segment will be restricted by the mild declines in the average SP (selling price).
